The Relationship Between Homocysteine and Manifestation of Parkinson's Disease Patients
NCT06849414 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 44
Last updated 2025-02-27
Summary
* The aim of the current study is to investigate the association between blood homocysteine level and motor as well as cognitive manifestation of PD patients in Assiut governorate.
* Secondary goal is to investigate the association between levels of serum ferritin, iron as well as acute phase proteins (fibrinogen, D-dimer, CRP) and manifestation of PD.
Conditions
- Parkinson's Disease
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-30
- Primary Completion
- 2026-06-30
- Completion
- 2026-07-31
More Related Trials
-
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
NCT02458430 ·Status: COMPLETED
-
Decrease in Sense of Smell and Associated Cognitive Decline in Parkinson's Disease
NCT01572142 ·Status: COMPLETED
-
Functional Characterization of Parkin + Patients
NCT00142311 ·Status: TERMINATED
-
Study on Serum Cystatin C and PET-DAT in Patients With Parkinson's Disease
NCT04926909 ·Status: UNKNOWN
-
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
NCT06283043 ·Status: ENROLLING_BY_INVITATION
-
Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations
NCT02060695 ·Status: RECRUITING
-
SHMT1 Polymorphism in Parkinson's Disease,
NCT04706065 ·Status: UNKNOWN
-
Retinal Function in Parkinson's Disease
NCT01010074 ·Status: UNKNOWN
-
Balance Performance and Corticomotor Inhibition in PD
NCT05066659 ·Status: UNKNOWN
-
Self-controlled Practice on Motor Learning and Motivation in Parkinson's Disease
NCT07028515 ·Status: RECRUITING
-
Attention and Eye Movement in Parkinson's Disease
NCT06899022 ·Status: RECRUITING ·Phase: NA
-
Analysis of Cortical Biomarkers for PD
NCT03645538 ·Status: UNKNOWN
-
Predictors of Parkinson's Disease Progression
NCT04062279 ·Status: UNKNOWN
-
Relationship Between Dopaminergic Asymmetric Degeneration and Attentional Resources in Parkinson's Disease.
NCT03476668 ·Status: COMPLETED ·Phase: NA
-
Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease
NCT06588920 ·Status: RECRUITING
-
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.
NCT06156917 ·Status: COMPLETED
-
N-Acetylcysteine for Neuroprotection in Parkinson's Disease
NCT01470027 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dementia Registry for Parkinson's Disease
NCT01251094 ·Status: COMPLETED
-
A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease
NCT04453995 ·Status: UNKNOWN
-
Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
NCT02445651 ·Status: COMPLETED ·Phase: NA
-
Self-Reports of Executive Functions in Persons With Parkinson's Disease and Their Significant Others
NCT04928027 ·Status: UNKNOWN
-
Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation
NCT01272687 ·Status: COMPLETED
-
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
NCT01427517 ·Status: COMPLETED ·Phase: PHASE1
-
One-year Follow-up of Iron in Basal Ganglia - R2*: a Biomarker of Parkinson's Disease Progression?
NCT02816645 ·Status: UNKNOWN ·Phase: NA
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
NCT07064005 ·Status: RECRUITING ·Phase: PHASE1